A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Pregabalin in Subjects With Generalized Anxiety Disorder (GAD) Switching From Benzodiazepine Therapy.

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Pregabalin in Subjects With Generalized Anxiety Disorder (GAD) Switching From Benzodiazepine Therapy.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Oct 2012

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Generalised anxiety disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Oct 2012 Planned number of patients changed from 80 to 120.
    • 15 Sep 2009 Results presented at the 22nd Annual Congress of the European College of Neuropsychopharmacology.
    • 12 Nov 2008 Status changed from recruiting to completed, as reported by clinicaltrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top